Search Results | American Association for Cancer Research

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Folate and Cancer Prevention—Where to Next? Counterpoint

Cornelia M. Ulrich

Cancer Epidemiol Biomarkers Prev (2008) 17 (9): 2226–2230.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-2952

Published: 02 September 2008

View article

Journal Articles

Folic Acid Supplementation and Cancer Risk: Point

Young-In Kim

Cancer Epidemiol Biomarkers Prev (2008) 17 (9): 2220–2225.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-2557

Published: 02 September 2008

View article

Journal Articles

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint

Janusz Jankowski, Richard Hunt

Cancer Epidemiol Biomarkers Prev (2008) 17 (8): 1858–1861.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0710

Published: 14 August 2008

View article

Journal Articles

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point

Nadir Arber

Cancer Epidemiol Biomarkers Prev (2008) 17 (8): 1852–1857.

DOI: https://doi.org/10.1158/1055-9965.EPI-08-0167

Published: 14 August 2008

View article

Journal Articles

Aspirin Should Not Be Promoted for Colon Cancer Prevention: Counterpoint

Robert S. Sandler

Cancer Epidemiol Biomarkers Prev (2008) 17 (7): 1562–1563.

DOI: https://doi.org/10.1158/1055-9965.EPI-06-0947

Published: 15 July 2008

View article

Journal Articles

Aspirin is Clinically Effective in Chemoprevention of Colorectal Neoplasia: Point

Moshe Leshno, Menachem Moshkowitz, Nadir Arber

Cancer Epidemiol Biomarkers Prev (2008) 17 (7): 1558–1561.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0259

Published: 15 July 2008

View article

Journal Articles

Human Papillomavirus Vaccination Should Be Offered to Young Males: Counterpoint

Cornelia L. Trimble

Cancer Epidemiol Biomarkers Prev (2008) 17 (4): 809.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-2930

Published: 08 April 2008

View article

Journal Articles

The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point

Anna R. Giuliano, Daniel Salmon

Cancer Epidemiol Biomarkers Prev (2008) 17 (4): 805–808.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0741

Published: 08 April 2008

View article

Journal Articles

Tamoxifen or Raloxifene in Postmenopausal Women for Prevention of Breast Cancer: A Tale of Two Choices—Counterpoint

Carol Fabian

Cancer Epidemiol Biomarkers Prev (2007) 16 (11): 2210–2212.

DOI: https://doi.org/10.1158/1055-9965.EPI-06-1065

Published: 15 November 2007

View article

Journal Articles

Tamoxifen or Raloxifene for Breast Cancer Chemoprevention: A Tale of Two Choices—Point

V. Craig Jordan

Cancer Epidemiol Biomarkers Prev (2007) 16 (11): 2207–2209.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0629

Published: 15 November 2007

View article

Journal Articles

Counterpoint: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention

Marianne Berwick

Cancer Epidemiol Biomarkers Prev (2007) 16 (10): 1923–1924.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0391

Published: 11 October 2007

View article

Journal Articles

Point: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention

Adèle C. Green, Gail M. Williams

Cancer Epidemiol Biomarkers Prev (2007) 16 (10): 1921–1922.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0477

Published: 11 October 2007

View article

Journal Articles

Counterpoint: Genetic Risk Feedback for Common Disease—Time to Test the Waters

Patricia A. Thompson

Cancer Epidemiol Biomarkers Prev (2007) 16 (9): 1727–1729.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0213

Published: 12 September 2007

View article

Journal Articles

Point: Genetic Risk Feedback for Common Disease—Time to Test the Waters

Colleen M. McBride, Lawrence C. Brody

Cancer Epidemiol Biomarkers Prev (2007) 16 (9): 1724–1726.

DOI: https://doi.org/10.1158/1055-9965.EPI-07-0102

Published: 12 September 2007

View article

Journal Articles

Biospecimen “Ownership”: Point

Roberta B. Ness, on behalf of the American College of Epidemiology Policy Committee

Cancer Epidemiol Biomarkers Prev (2007) 16 (2): 188–189.

DOI: https://doi.org/10.1158/1055-9965.EPI-06-1011

Published: 14 February 2007

View article

Journal Articles

Biospecimen “Ownership”: Counterpoint

Lynn G. Dressler

Cancer Epidemiol Biomarkers Prev (2007) 16 (2): 190–191.

DOI: https://doi.org/10.1158/1055-9965.EPI-06-1004

Published: 14 February 2007

View article

Journal Articles

Not the Time to Abandon the Food Frequency Questionnaire: Counterpoint

Alan R. Kristal, John D. Potter

Cancer Epidemiol Biomarkers Prev (2006) 15 (10): 1759–1760.

DOI: https://doi.org/10.1158/1055-9965.EPI-06-0727

Published: 11 October 2006

View article

Journal Articles

Not the Time to Abandon the Food Frequency Questionnaire: Point

Walter C. Willett, Frank B. Hu

Cancer Epidemiol Biomarkers Prev (2006) 15 (10): 1757–1758.

DOI: https://doi.org/10.1158/1055-9965.EPI-06-0388

Published: 11 October 2006

View article

Journal Articles

Counterpoint: Because Some Surrogate End Point Biomarkers Measure the Neoplastic Process They Will Have High Utility in the Development of Cancer Chemopreventive Agents against Sporadic Cancers

Gary J. Kelloff, Joyce A. O’Shaughnessy, Gary B. Gordon, Ernest T. Hawk, Caroline C. Sigman

Cancer Epidemiol Biomarkers Prev (2003) 12 (7): 593–596.

Published: 17 July 2003

View article

Journal Articles

Point: Surrogate End Point Biomarkers Are Likely To Be Limited in Their Usefulness in the Development of Cancer Chemoprevention Agents against Sporadic Cancers

William B. Armstrong, Thomas H. Taylor, Frank L. Meyskens, Jr.

Cancer Epidemiol Biomarkers Prev (2003) 12 (7): 589–592.

Published: 17 July 2003

View article

NARROW

Folate and Cancer Prevention—Where to Next? Counterpoint

Folic Acid Supplementation and Cancer Risk: Point

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point

Aspirin Should Not Be Promoted for Colon Cancer Prevention: Counterpoint

Aspirin is Clinically Effective in Chemoprevention of Colorectal Neoplasia: Point

Human Papillomavirus Vaccination Should Be Offered to Young Males: Counterpoint

The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point

Tamoxifen or Raloxifene in Postmenopausal Women for Prevention of Breast Cancer: A Tale of Two Choices—Counterpoint

Tamoxifen or Raloxifene for Breast Cancer Chemoprevention: A Tale of Two Choices—Point

Counterpoint: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention

Point: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention

Counterpoint: Genetic Risk Feedback for Common Disease—Time to Test the Waters

Point: Genetic Risk Feedback for Common Disease—Time to Test the Waters

Biospecimen “Ownership”: Point

Biospecimen “Ownership”: Counterpoint

Not the Time to Abandon the Food Frequency Questionnaire: Counterpoint

Not the Time to Abandon the Food Frequency Questionnaire: Point

Counterpoint: Because Some Surrogate End Point Biomarkers Measure the Neoplastic Process They Will Have High Utility in the Development of Cancer Chemopreventive Agents against Sporadic Cancers

Point: Surrogate End Point Biomarkers Are Likely To Be Limited in Their Usefulness in the Development of Cancer Chemoprevention Agents against Sporadic Cancers

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only